Abstract

Addressing the underlying components of idiopathic scoliosis, including hormone and neurotransmitter imbalances, has the potential to improve scoliosis treatment outcomes. While the precise relationship between these imbalances and scoliosis development is not fully understood, emerging evidence suggests that correcting these imbalances may positively influence the progression and management of idiopathic scoliosis. The functional medicine model of patient evaluation and treatment may offer some insight as to more robustly, and possibly effectively, manage the entire idiopathic scoliosis condition. This review describes many of the known underlying abnormalities associated with idiopathic scoliosis and offers perspective and ideas for future research into comprehensive idiopathic scoliosis management.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.